ज्यादा पढ़ी गई:
We refer to our letter dated September 18 2024 informing that the Company entered into binding agreement with GLS Pharma Limited (GLS) a subsidiary of the Company and its promoters for acquisition of balance 590361 equity sharesof INR 10/- each (49% of GLS) for a purchase consideration of INR22.50 crores. The aforementioned acquisition has been completed on October 25 2024 and GLS has become wholly owned subsidiary of the Company.
हाल में देखा गया
सब क्लियर करें
